Transcriptomic Analysis of the Activity and Mechanism of Action of a Ruthenium(II)-Based Antimicrobial That Induces Minimal Evolution of Pathogen Resistance. (2021)
Attributed to:
Advancing early stage healthcare research in Sheffield
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acsptsci.0c00159
PubMed Identifier: 33615170
Publication URI: http://europepmc.org/abstract/MED/33615170
Type: Journal Article/Review
Volume: 4
Parent Publication: ACS pharmacology & translational science
Issue: 1
ISSN: 2575-9108